Tongji Medical College is a medical school in Wuhan, China. Formerly Tongji Medical University, it became part of the newly established Huazhong University of Science and Technology in 2000.

During the past decade, Tongji Hospital conducted 405 clinical trials. In the 10-year time frame, 405 clinical trials started and 56 clinical trials were completed, i.e. on average, 13.8% percent of trials that started reached the finish line to date. In the past 5 years, 222 clinical trials started and 37 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tongji Hospital" #1 sponsor was "Tongji Hospital" with 94 trials, followed by "Huazhong University of Science and Technology" with 66 trials sponsored, "Hoffmann-La Roche" with 19 trials sponsored, "Pfizer" with 15 trials sponsored and "BeiGene" with 15 trials sponsored. Other sponsors include 303 different institutions and companies that sponsored additional 165 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tongji Hospital" #1 collaborator was "Tongji Hospital" with 28 trials as a collaborator, "Qilu Hospital of Shandong University" with 14 trials as a collaborator, "Peking University First Hospital" with 12 trials as a collaborator, "LinkDoc Technology (Beijing) Co. Ltd." with 10 trials as a collaborator and "First Affiliated Hospital of Guangxi Medical University" with 9 trials as a collaborator. Other collaborators include 912 different institutions and companies that were collaborators in the rest 477 trials.

According to Clinical.Site data, the most researched conditions in "Tongji Hospital" are "Cervical Cancer" (15 trials), "Non-small Cell Lung Cancer" (11 trials), "Surgery" (11 trials), "Gastric Cancer" (10 trials) and "Hepatitis B, Chronic" (10 trials). Many other conditions were trialed in "Tongji Hospital" in a lesser frequency.

Most popular intervention types in "Tongji Hospital" are "Drug" (326 trials), "Procedure" (57 trials), "Other" (39 trials), "Biological" (30 trials) and "Device" (25 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "Cisplatin" (9 trials), "placebo" (8 trials), "Carboplatin" (7 trials) and "Zanubrutinib" (7 trials). Other intervention names were less common.

The vast majority of trials in "Tongji Hospital" are 440 trials for "All" genders, 58 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are 230 active trials in "Tongji Hospital". 16 are not yet recruiting, 145 are recruiting, 63 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 164 completed trials in Tongji Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Tongji Hospital, 32 "Phase 1" clinical trials were conducted, 86 "Phase 2" clinical trials and 146 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 56 trials, and there were also 94 trials that are defined as “Not Applicable".